Resonance Health (ASX:RHT): A potential game-changer in diagnosing liver fibrosis
Andrew Harrison, Managing Director of Resonance Health (ASX:RHT), spoke with Stocks Down Under about the company’s recent progress in developing an MRI-based diagnostic that can accurately measure liver fibrosis.
Read the full article here: Stocks Down Under